Cornerstone Planning Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$387K Buy
3,033
+53
+2% +$6.2K 0.05% 122
2026
Q1
$337K Buy
2,980
+295
+11% +$34.1K 0.05% 123
2025
Q4
$287K Sell
2,685
-637
-19% -$59.8K 0.04% 118
2025
Q3
$287K Buy
3,322
+420
+14% +$34.6K 0.05% 112
2025
Q2
$234K Sell
2,902
-20
-0.7% -$1.59K 0.05% 78
2025
Q1
$230K Buy
2,922
+801
+38% +$74.8K 0.06% 80
2024
Q4
$208K Buy
2,121
+703
+50% +$72.5K 0.05% 70
2024
Q3
$147K Sell
1,418
-37
-3% -$4.4K 0.04% 93
2024
Q2
$163K Sell
1,455
-49
-3% -$6.31K 0.05% 89
2024
Q1
$192K Sell
1,504
-108
-7% -$13.3K 0.06% 76
2023
Q4
$176K Sell
1,612
-166
-9% -$17.2K 0.06% 88
2023
Q3
$183K Buy
1,778
+367
+26% +$39.6K 0.07% 81
2023
Q2
$163K Buy
+1,411
New +$160K 0.06% 98
2022
Q4
$227K Buy
+2,065
New +$211K 0.1% 90

Other funds holding MRK

Cornerstone Planning Group's MRK Position: Q2 2026 in Review

Cornerstone Planning Group increased its Merck (MRK) stake by 1.8% in Q2 2026, buying an estimated $6.2K and bringing the position to 3,033 shares worth $387K. The position accounts for 0.05% of the portfolio, ranked #122.

Cornerstone Planning Group first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cornerstone Planning Group held 3,033 shares of Merck worth $387K as of Q2 2026.
  • Cornerstone Planning Group bought 53 Merck shares in Q2 2026, an estimated $6.2K.
  • Merck made up 0.05% of Cornerstone Planning Group's portfolio in Q2 2026, its #122 holding.
  • Cornerstone Planning Group first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.